UnitedHealth Group Incorporated (NYSE:UNH) increased its holdings by Genesee Capital Advisors LLC


Genesee Capital Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet a rating) by 13.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,880 shares of the healthcare conglomerate’s stock after purchasing an additional 341 shares during the quarter. UnitedHealth Group comprises 1.0% of Genesee Capital Advisors LLC’s holdings, making the stock its 27th largest position. Genesee Capital Advisors LLC’s holdings in UnitedHealth Group were worth $1,479,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in UNH. Advocacy Wealth Management Services LLC increased its position in UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. raised its stake in shares of UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 30 shares in the last quarter. Rothschild & Co Wealth Management UK Ltd bought a new stake in shares of UnitedHealth Group in the second quarter valued at $31,000. Rise Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $38,000. Finally, Evolution Advisers Inc. acquired a new stake in shares of UnitedHealth Group in the first quarter valued at $38,000. 87.25% of shares are owned by hedge funds and other institutional investors.

Insiders make bets

In other news, UnitedHealth Group, CAO Thomas E. Roos sold 465 shares of the stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction amounting to $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a legal filing with the SEC, which can be accessed via this hyperlink. In other news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37 for a total value of $252,202.05. Following the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was reported in a legal filing with the Securities and Exchange Commission, which can be accessed at SEC website. In addition, the general director Dirk S. McMahon sold 14,715 shares of the firm’s stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $543.32, for a total transaction amounting to $7,994,953.80. Following the completion of the transaction, the chief executive officer now directly owns 50,108 shares in the company, valued at approximately $27,224,678.56. Disclosures for this sale can be found here here. Insiders have sold a total of 139,051 shares of company stock valued at $74,450,958 over the last 90 days. 0.40% of shares are currently owned by insiders.

Analysts set new price targets

A number of brokerages recently weighed in on UNH. Morgan Stanley upped their target price on shares of UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Mizuho upped their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. Raymond James upped their target price on shares of UnitedHealth Group from $620.00 to $635.00 and gave the stock a “strong-buy” rating in a research report on Thursday, September 22nd. UBS Group upped their target price on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research report on Thursday, July 21st. Finally, Argus boosted their target price on shares of UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research report on Monday, July 25th. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the stock. UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $586.40, according to MarketBeat.com.

UnitedHealth Group shares fell 0.7%

ENT opened at $505.04 on Friday. The 50 day simple moving average is $528.35 and the 200 day simple moving average is $513.42. The company has a debt-to-equity ratio of 0.60, a gearing ratio of 0.77, and a current ratio of 0.77. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The firm has a market cap of $472.40 billion, a price-to-earnings ratio of 26.37, a PEG ratio of 1.59 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet a rating) last published its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. During the same quarter last year, the company earned $4.70 per share. The company’s quarterly revenue grew by 12.6% compared to the same period last year. equities research analysts expect that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current fiscal year.

UnitedHealth Group announces dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were paid a dividend of $1.65 per share. This represents an annualized dividend of $6.60 and a yield of 1.31%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

About UnitedHealth Group

(Get a rating)

UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates in four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health care plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care and wellness services for people age 50 and older that meet their needs for preventive and emergency health care, as well as services related to chronic diseases and other specialized problems for older adults; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended stories



Get UnitedHealth Group news and ratings daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies MarketBeat.com’s FREE Daily E-Newsletter.

https://www.defenseworld.net/2022/10/01/unitedhealth-group-incorporated-nyseunh-holdings-increased-by-genesee-capital-advisors-llc.html UnitedHealth Group Incorporated (NYSE:UNH) increased its holdings by Genesee Capital Advisors LLC

Exit mobile version